Gezgin, Funda
Eyer, Florian
Zorn, Gabriel
Schaper, Andreas
Wagner, Rafael
Seifert, Roland
Funding for this research was provided by:
Medizinische Hochschule Hannover (MHH)
Article History
Received: 24 June 2026
Accepted: 30 July 2026
First Online: 6 August 2026
Declarations
Ethics approval: This research was conducted according to the guidelines of good scientific practice of the Hannover Medical School ( ) and officially registered as doctoral thesis project for Funda Gezgin. The Hannover Medical School follows the guidelines of the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG).
Consent for publication: Not applicable because publicly available information is used as data source.
Competing interests: D.P., F.E., F.G., G.Z., A.S. and R.W declare no competing interests. R.S. is the Editor-in-Chief of Naunyn-Schmiedebergs Arch Pharmacol and follows the editorial guidelines for editors acting as authors ( ).